NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 358 filers reported holding NOVOCURE LTD in Q4 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -85.7% | 42 | -85.8% | 0.00% | -100.0% |
| Q2 2022 | $21,000 | +75.0% | 296 | +112.9% | 0.00% | +100.0% |
| Q1 2022 | $12,000 | +1100.0% | 139 | +1637.5% | 0.00% | – |
| Q4 2021 | $1,000 | -93.3% | 8 | -93.7% | 0.00% | -100.0% |
| Q3 2021 | $15,000 | -92.8% | 127 | -86.4% | 0.00% | -95.2% |
| Q2 2021 | $208,000 | +1200.0% | 936 | +673.6% | 0.02% | +950.0% |
| Q1 2021 | $16,000 | +33.3% | 121 | +77.9% | 0.00% | 0.0% |
| Q4 2020 | $12,000 | +1100.0% | 68 | +518.2% | 0.00% | – |
| Q3 2020 | $1,000 | – | 11 | +83.3% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 6 | -64.7% | 0.00% | – |
| Q4 2019 | $1,000 | – | 17 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $27,923,000 | 10.09% |
| Darsana Capital Partners LP | 1,700,000 | $100,810,000 | 5.98% |
| HARTLINE INVESTMENT CORP/ | 336,617 | $19,961,000 | 4.18% |
| Rhenman & Partners Asset Management AB | 375,000 | $22,238,000 | 2.40% |
| MORGAN JESS S & CO INC | 35,942 | $2,131,000 | 2.31% |
| Soleus Capital Management, L.P. | 56,397 | $3,344,000 | 1.91% |
| Bullseye Asset Management LLC | 45,161 | $2,678,000 | 1.43% |
| Taylor Frigon Capital Management LLC | 46,304 | $2,746,000 | 1.36% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $593,000 | 1.09% |
| Redwood Investments, LLC | 192,986 | $11,444,000 | 1.01% |